Pages that link to "Q55458621"
Jump to navigation
Jump to search
The following pages link to Andrew S Moore (Q55458621):
Displaying 50 items.
- Optimization of Imidazo[4,5- b ]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid Leukemia (Q27674324) (← links)
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors (Q33882326) (← links)
- Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia (Q34314927) (← links)
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs (Q34515911) (← links)
- Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy (Q35049985) (← links)
- EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia (Q35666005) (← links)
- Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns (Q36469916) (← links)
- Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma (Q36774588) (← links)
- Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis (Q37004219) (← links)
- Vincristine sulfate liposomal injection for acute lymphoblastic leukemia (Q37305758) (← links)
- Vincristine: Can its therapeutic index be enhanced? (Q37545848) (← links)
- Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias. (Q37690579) (← links)
- Novel therapies for children with acute myeloid leukaemia. (Q38096798) (← links)
- Intertumoral Heterogeneity within Medulloblastoma Subgroups (Q38671456) (← links)
- The MLL recombinome of acute leukemias in 2017. (Q38681972) (← links)
- A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia. (Q38788657) (← links)
- Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemia. (Q39526264) (← links)
- Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors. (Q40859498) (← links)
- The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry. (Q41099096) (← links)
- Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia (Q41467756) (← links)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma (Q42375231) (← links)
- BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group (Q43092984) (← links)
- HG-76SPATIAL AND TEMPORAL HOMOGENEITY OF DRIVER MUTATIONS IN DIFFUSE INTRINSIC PONTINE GLIOMA. (Q46352174) (← links)
- High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment (Q47142310) (← links)
- The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion (Q47853157) (← links)
- Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions (Q47864993) (← links)
- Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? (Q48231823) (← links)
- Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? (Q48303270) (← links)
- Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours (Q49802373) (← links)
- Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia. (Q50042497) (← links)
- EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia. (Q51283425) (← links)
- Molecular Minimal Residual Disease Monitoring in Acute Myeloid Leukemia: Challenges and Future Directions. (Q52310957) (← links)
- Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. (Q55456542) (← links)
- ALK2 inhibitors display beneficial effects in preclinical models of mutant diffuse intrinsic pontine glioma (Q64059831) (← links)
- Localised peripheral primitive neuroectodermal tumour (PNET) of the conjunctiva (Q83984423) (← links)
- A stable-isotope HPLC-MS/MS method to simplify storage of human whole blood samples for glutathione assay (Q84170546) (← links)
- Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach (Q84317550) (← links)
- Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children (Q89505912) (← links)
- Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes (Q90832636) (← links)
- PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors (Q90912327) (← links)
- Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study (Q91248929) (← links)
- Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study (Q91294837) (← links)
- Second primary cancers in people who had cancer as children: an Australian Childhood Cancer Registry population-based study (Q91339139) (← links)
- Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736 (Q91861935) (← links)
- Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry (Q91896511) (← links)
- Invasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003-2013 (Q91915653) (← links)
- Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission: A report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group (Q92182194) (← links)
- The incidence of childhood cancer in Australia, 1983-2015, and projections to 2035 (Q92250700) (← links)
- Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma (Q98191465) (← links)
- Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer (Q100455172) (← links)